Buprenorphine 58118-0502-08
- Manufacturer
- Clinical Solutions Wholesale, Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 25, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA207276
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
58118-0502-08Selected30 TABLET in 1 BLISTER PACK (58118-0502-8)